Related Experiment Video
Updated: Aug 16, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
mtDNA mutations and common neurodegenerative disorders
Neil Howell1, Joanna L Elson, Patrick F Chinnery
1Migenix Corporation, San Diego, CA 92130, USA.
Abstract:
The incidence and prevalence of Alzheimer's disease (AD) and Parkinson's disease (PD) are increasing as the population ages. Both disorders have been associated with oxidative stress and mitochondrial dysfunction, and it has been proposed that mutations in the mitochondrial genome have a key role in neurodegeneration in AD and PD patients. Two recent publications propose that heteroplasmic mtDNA mutations are involved in AD and PD. However, when these new studies are considered in relation to the sum of previous evidence, the role of mtDNA mutations in the development of either AD or PD still remains to be established.
Insights
Mitochondrial DNA (mtDNA) mutations are investigated for their role in neurodegenerative diseases like Alzheimer's disease (AD) and Parkinson's disease (PD). Current evidence is inconclusive regarding the direct involvement of mtDNA mutations in AD and PD pathogenesis.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Alzheimer's disease (AD) and Parkinson's disease (PD) incidence is rising with aging populations.
- Both AD and PD are linked to oxidative stress and mitochondrial dysfunction.
- Mitochondrial genome mutations are hypothesized to contribute to neurodegeneration in AD and PD.
Purpose of the Study:
- To evaluate the role of heteroplasmic mitochondrial DNA (mtDNA) mutations in Alzheimer's disease (AD) and Parkinson's disease (PD).
Main Methods:
- Review and synthesis of recent publications and existing evidence on mtDNA mutations in neurodegenerative diseases.
Main Results:
- Recent studies suggest a potential involvement of heteroplasmic mtDNA mutations in AD and PD.
- However, the overall body of evidence remains insufficient to establish a definitive role.
Conclusions:
- The precise contribution of mitochondrial DNA mutations to the development of Alzheimer's disease and Parkinson's disease requires further investigation.
- Establishing the role of mtDNA mutations is crucial for understanding neurodegeneration in AD and PD.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Alzheimer Disease l: Introduction
Animal Mitochondrial Genetics
Parkinson Disease ll: Pathophysiology
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
